A Trial for Patients With Gestational Trophoblastic Disease

NCT00190918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Trophoblastic Neoplasms
Uterine Neoplasms
Hydatidiform Mole
Choriocarcinoma

Interventions

DRUG: Pemetrexed

Sponsor

Eli Lilly and Company

Collaborators

[object Object]